Singapore markets close in 45 minutes
Straits Times Index
3,302.37 +9.44 (+0.29%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,547.97 +72.05 (+0.39%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,534.54 +854.07 (+1.34%) CMC Crypto 200
1,374.21 +61.59 (+4.69%)
ABT Jun 2025 90.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:40PM EDT. Market open.
| Previous close | 26.50 |
| Open | N/A |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 90.00 |
| Expiry date | 2025-06-20 |
| Day's range | 26.50 - 26.50 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.